BioArk Partners — Boutique Investment Bank for Healthcare

BioArk Partners is a leading Chinese boutique investment bank specializing in the healthcare and life sciences sector. Headquartered in Shanghai and Beijing, our global reach includes a presence in North America, India, Korea, Japan and Europe.
10Years+
Industry Experience
120+
Enterprises Served
50Billion RMB
Transaction Amount

About Us

Your Most Reliable Partner

Founded in 2022, BioArk Partners specializes in investment banking services for the healthcare companies. Our team brings together professionals with dual expertise in the healthcare industry and investment banking, and maintains deep collaborations with leading Chinese healthcare enterprises, top-tier investment institutions and multinational pharmaceutical companies.

Our Mission

Our Mission

Help Chinese healthcare innovators secure capital and drive industry growth.

Our Vision

Our Vision

To be the most trusted boutique investment bank in China's healthcare sector.

About BioArk

Our Services

Integrated Services, End-to-End Empowerment

Fundraising

Fundraising

Full-spectrum fundraising services covering all stages from Angel to IPO, as well as M&A and restructuring needs. Over RMB 50 billion raised since 2020.

Business Development

Business Development

License-in, License-out, co-development, and other BD transactions to expand product pipelines and markets.

Strategic Advisory

Strategic Advisory

Strategic planning, valuation analysis, and investor relations management based on deep industry insights and investor perspective.

NewCo Services

NewCo Services

Specialized in NewCo transactions, helping companies maximize value through asset carve-outs and joint ventures.

Recent Transactions

Proven Track Record

Biotech | CNS
Angel++
Investor 1
Biotech | ADPKD
Series A
Investor 1Investor 2Investor 3
AI-driven Protein Design
Series Pre-A
Investor 1Investor 2
Biotech | Metabolic
Series A
Investor 1Investor 2Investor 3
MedTech | BioRobotics
Series B
Investor 1
Biotech | Oncology
Series D+/D++
Investor 1Investor 2Investor 3Investor 4Investor 5Investor 6
Biotech | Oncology
Series A+
Investor 1Investor 2Investor 3Investor 4Investor 5
Biotech | Allergy & I&I
Series D
Investor 1Investor 2Investor 3
MedTech | Aesthetic Medical Devices
Series B/B+
Investor 1
MedTech | OCT
Series D
Investor 1Investor 2
Biotech | PROTAC
Series Pre-A
Investor 1Investor 2Investor 3
Nucleic Acid Synthesis
Series B
Investor 1
CDMO
Series C/C+
Investor 1Investor 2Investor 3Investor 4
MedTech | Cryobiopsy
Series C
Investor 1
Biotech | Ophthalmic
Series B
Investor 1Investor 2Investor 3Investor 4
Biotech | CAR-T
Series C+
Investor 1Investor 2Investor 3Investor 4Investor 5Investor 6
Biotech | Gene Therapy
Series B
Investor 1Investor 2Investor 3
MedTech | OCT
Series C
Investor 1Investor 2
Biotech | Hemophilia
Series C+
Investor 1Investor 2Investor 3Investor 4

Contact Us

We look forward to exploring collaboration opportunities with you. Whether you seek business discussion, private equity financing, BD partnerships, or strategic advisory, our professional team will provide customized solutions.

Address

Shanghai: Unit 10, 6th Floor, Azia Center Property Management Office, 1233 Lujiazui Ring Road, Pudong New Area, Shanghai, China

Beijing: Suite 2713, China Merchants Tower, No.118 Jianguo Road, Chaoyang District, Beijing, China